Benjamin F. Edwards & Company, Inc. Adial Pharmaceuticals, Inc. Put Options Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADIL
# of Institutions
1Shares Held
5.5KCall Options Held
0Put Options Held
0About ADIAL PHARMACEUTICALS, INC.
- Ticker ADIL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,854,000
- Market Cap $27.1M
- Description
- Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...